National Security Commission on Emerging Biotechnology
A bipartisan independent commission established by the United States Congress under the Fiscal Year 2022 National Defense Authorization Act. It assesses the national security implications of the intersection of AI and biotechnology and recommends policies on legislation, regulation, investment and talent.
Timeline (last 90 days)
MIT Lincoln Laboratory recently hosted a roadshow event for the National Security Commission on Emerging Biotechnology.
The National Security Commission on Emerging Biotechnology is a bipartisan independent commission established by the U.S. Congress pursuant to the Fiscal Year 2022 National Defense Authorization Act.
The duty of the National Security Commission on Emerging Biotechnology is to assess the impact of the intersection of artificial intelligence and biotechnology on U.S. national security and to make recommendations on legislation, regulation, investment, and talent policy.
The National Security Commission on Emerging Biotechnology focuses on issues such as biomanufacturing, biosecurity of biological data, dual-use risks of synthetic biology, and U.S. bioeconomy competitiveness.
The commission's roadshow activities aim to identify capability gaps and policy friction points in the industrial and research ecosystem, providing a basis for strategic planning at the federal level.
All Facts (5)
The National Security Commission on Emerging Biotechnology is a bipartisan independent commission established by the U.S. Congress pursuant to the Fiscal Year 2022 National Defense Authorization Act.
50%UnverifiedThe duty of the National Security Commission on Emerging Biotechnology is to assess the impact of the intersection of artificial intelligence and biotechnology on U.S. national security and to make recommendations on legislation, regulation, investment, and talent policy.
50%UnverifiedThe National Security Commission on Emerging Biotechnology focuses on issues such as biomanufacturing, biosecurity of biological data, dual-use risks of synthetic biology, and U.S. bioeconomy competitiveness.
50%UnverifiedThe commission's roadshow activities aim to identify capability gaps and policy friction points in the industrial and research ecosystem, providing a basis for strategic planning at the federal level.
50%UnverifiedMIT Lincoln Laboratory recently hosted a roadshow event for the National Security Commission on Emerging Biotechnology.
50%